Inhibikase Therapeutics, Inc. / Fundamental strength relative to industry (Mohanram G-Value) /

    The G-Value, developed by Mohanram in 2005, is a measure of a fundamental strength for growth companies. According to Mohanram, a low G-Value suggests a higher probability that a stock may be overvalued relative to its growth potential due to hype or overexcitement. The approach is described in detail in Mohanram's 2005 Paper Separating Winners from Losers among LowBook-to-Market Stocks using Financial Statement Analysis.

    You are viewing the G-Value as of . Click to view the current G-Value instead.

    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7
    Return on assets (ROA) greater than industry median
    close -61.4% ≤ -61.4%
    Operating cash flow over total assets greater than industry median
    close -68.8% ≤ -61.2%
    Operating cash flow greater than net income
    close -$16.60M ≤ -$14.81M
    Variance in ROA over the last 5 years less than industry median
    close 105,176.3% ≥ 8.9%
    Variance in year-over-year sales growth over the last 5 years less than industry median
    close 27.7% ≥ 25.7%
    R&D expenses over total assets greater than industry median
    check 42.2% > 39.4%
    Capex over total assets greater than industry median
    close 0.2% ≤ 0.8%

    G-Value history

    The G-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the G-Value at a specific time in the past.

    5
    3
    3
    4
    1
    3
    3
    4
    3
    3
    2
    3
    1
    2
    2
    3
    2
    2
    2
    3
    4
    3

    Notifications